Articles

Phenotype-based drug screening reveals association between venetoclax response and differentiation stage in acute myeloid leukemia

Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki;Hematology Research Unit, Helsinki University Hospital Comprehensive Cancer Center, Helsinki
Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki
Institute of Biomedicine, School of Medicine, University of Eastern Finland, Kuopio, Finland
Hematology Research Unit, Helsinki University Hospital Comprehensive Cancer Center, Helsinki
Hematology Research Unit, Helsinki University Hospital Comprehensive Cancer Center, Helsinki
Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki
Hematology Research Unit, Helsinki University Hospital Comprehensive Cancer Center, Helsinki
Hematology Research Unit, Helsinki University Hospital Comprehensive Cancer Center, Helsinki
Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki
Department of Hematology and Oncology, University of Tartu, Tartu, Estonia
Centre for Cancer Biomarkers, Department of Clinical Science, University of Bergen, Bergen, Norway
Institute of Biomedicine, School of Medicine, University of Eastern Finland, Kuopio, Finland
Hematology Research Unit, Helsinki University Hospital Comprehensive Cancer Center, Helsinki
Hematology Research Unit, Helsinki University Hospital Comprehensive Cancer Center, Helsinki;Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland
Institute for Molecular Medicine Finland, Helsinki Institute of Life Science, University of Helsinki, Helsinki
Vol. 105 No. 3 (2020): March, 2020 https://doi.org/10.3324/haematol.2018.214882